Ionis Update on Clinical Trial for Hereditary TTR – ASG Webinar 10/11

ASG’s Northeastern regional webinar on ATTR amyloidosis, recorded on July 10, 2021.
The webinar is presented by: Gustavo Buchele, MD, PhD, Medical Director, Ionis Pharmaceutical Inc